Tags - Sanofi buysSanofi buys

France's Sanofi buys Ablynx for $4.8 billion in biotech M&A boom

TEHRAN, January 29 -French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.

News ID: 18529 Publish Date : 2018/01/29

Young journalists club

France's Sanofi buys Ablynx for $4.8 billion in biotech M&A boom

China’s EXIM inks $1.5bn deal for high-speed rail in Iran (1 Comment)